Table 5 Within group effects: Planned risk reduction strategies across with the decision aid
Planned CHD Interventions | In Decision Aid Group (n = 41) | ||
|---|---|---|---|
Baseline | Post-DA | Absolute Difference (95% CI) * | |
BP med, if HTN (n = 13) | 8% | 54% | +46% (9% to 75%) |
Cholesterol med, If abnormal chol (n = 19) | 5% | 26% | +21% (-5% to 47%) |
Smoking cessation, if smoking (n = 19) | 21% | 37% | +16% (-15% to 44%) |
Aspirin, If high risk (> 10%; n = 17) | 6% | 53% | +47% (19% to 72%) |
Diet low in saturated fat, all (n = 41) | 27% | 37% | +10% (-8% to 27%) |
Exercise regularly, all (n = 41) | 29% | 34% | +5% (-12% to 21%) |